FINWIRES · TerminalLIVE
FINWIRES

$NXTC

4 stories mentioning NXTCUpdated 61d ago

Every FINWIRES story that references NXTC, newest first.

What's the latest news on NXTC?

Sectors

Sector Update: Healthcare Stocks Fall Late Afternoon

Healthcare stocks fell late Tuesday afternoon with the NYSE Healthcare Index declining 1.7% and the State Street Health Care Select Sector SPDR ETF (XLV) dropping 1.9%.The iShares Biotechnology ETF (IBB) shed 0.4%.In corporate news, the US Justice Department recently sent civil investigative demands, which are similar to subpoenas, to lawyers for a group of hospitals and doctor groups suing Claritev (CTEV) for alleged antitrust violations, Bloomberg reported. Claritev shares fell 5.1%.HCA Healthcare (HCA) shares dropped 7.2% after the company lowered its 2026 adjusted diluted EPS guidance. Stephens cut its price target on the stock to $480 from $500, while keeping its overweight rating.IM8, a nutritional supplements company co-founded by Prenetics Global (PRE) and David Beckham, has lined up about $1 billion in growth financing from General Catalyst, Bloomberg reported. Prenetics shares jumped 17%.NextCure (NXTC) shares almost tripled after the company agreed to merge with privately held Avere Therapeutics in an all-stock deal.

$CTEV$HCA$NXTC$PRE
Wire

Top Midday Gainers

NextCure (NXTC) will merge with privately held Avere Therapeutics in an all-stock transaction to advance Avere's lead oral IL-23 therapy, AVR-001, for inflammatory diseases, the company said.Shares catapulted 200% as intraday trading volume soared to over 101 million from a daily average of about 103,000.Shuttle Pharmaceuticals (SHPH) soared 36% after a regulatory filing showed HRT Financial bought additional shares of the firm.More than 50.1 million shares were traded intraday, compared with a daily average of about 1.1 million.Goldman Sachs' (GS) Q2 results topped analysts' estimates as a record performance in the global banking and markets business propelled revenue growth.Shares jumped 7.6%, with intraday trading volume rising to over 2.3 million from a daily average of about 2.1 million.Price: $1127.05, Change: $+81.14, Percent Change: +7.76%

$GS$NXTC$SHPH
Sectors

Sector Update: Healthcare Stocks Fall Tuesday Afternoon

Healthcare stocks were lower Tuesday afternoon, with the NYSE Healthcare Index down 1.6% and the State Street Health Care Select Sector SPDR ETF (XLV) falling 1.8%.The iShares Biotechnology ETF (IBB) was fractionally lower.In corporate news, the US Justice Department recently sent civil investigative demands, which are similar to subpoenas, to lawyers for a group of hospitals and doctor groups suing Claritev (CTEV) for alleged antitrust violations, Bloomberg reported. Claritev shares fell past 11%.HCA Healthcare (HCA) shares dropped 7.3% after the company lowered its 2026 adjusted diluted EPS guidance. Stephens cut the company's price target to $480 from $500, while keeping its overweight rating.NextCure (NXTC) will merge with privately held Avere Therapeutics in an all-stock deal to advance Avere's lead oral IL-23 therapy, AVR-001, for inflammatory diseases, the company said. NextCure shares surged 200%.

$CTEV$HCA$NXTC
Sectors

Sector Update: Healthcare Stocks Mixed Premarket Tuesday

Healthcare stocks were mixed premarket Tuesday, with the State Street Health Care Select Sector SPDR ETF (XLV) down 0.3% and the iShares Biotechnology ETF (IBB) 0.1% higher.HCA Healthcare (HCA) shares were down more than 9% after the company cut its 2026 adjusted diluted EPS guidance.NextCure (NXTC) will merge with privately held Avere Therapeutics in an all-stock transaction to advance Avere's lead oral IL-23 therapy, AVR-001, for inflammatory diseases, the company said. NextCure shares were surging past 313% pre-bell.Spero Therapeutics (SPRO) has licensed exclusive worldwide rights, excluding Greater China, to develop and commercialize Innovent Biologics' immunology drug candidate, IBI355, under a deal valued at up to about $1.1 billion, the companies said. Spero Therapeutics stock was up 0.5% premarket.

$HCA$IBB$NXTC$SPRO$XLV

Track with the FINWIRES app suite